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DoxycyclineMitochondria-to-nucleus communication, known as retrograde signaling, is important to adjust the nuclear gene
expression in response to organelle dysfunction. Among the transcription factors described to respond to mito-
chondrial stress, CHOP-10 is activated by respiratory chain inhibition, mitochondrial accumulation of unfolded
proteins and mtDNA mutations. In this study, we show that altered/impaired expression of mtDNA induces
CHOP-10 expression in a signaling pathway that depends on the eIF2α/ATF4 axis of the integrated stress
response rather than on the mitochondrial unfolded protein response.
© 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.1. Introduction
Vestige of its α-proteobacterial origin, mitochondria keep DNA
(mtDNA) encoding 13 polypeptides, all subunits of the electron trans-
port chain (ETC), as well as 2 ribosomal RNAs (rRNAs) and 22 transfer
RNAs (tRNAs) that are required for their translation. Still, this only
represents 1% of the mitochondrial proteome, estimated at up to 1500
proteins that are therefore predominantly encoded by the nuclear
DNA (Calvo and Mootha, 2010). Altered expression of mitochondrial
proteins is increasingly associated with many and various humanTF4,activatingtranscriptionfac-
inase2;CREB,cAMP-responsive
α, eukaryotic translation initia-
rotein degradation; ERSE, endo-
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NA, mitochondrial DNA; NFAT,
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n kinase double-stranded RNA-
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ch Society. All rights reserved.diseases (Boczonadi and Horvath, 2014). If mutations within genes
encoding components or assembly factors of the ETC are themost obvi-
ous cause of mitochondrial dysfunction and pathology, the better
understanding of mtDNA maintenance and expression has shed light
on new mutations associated with mitochondrial diseases. Indeed,
those not only arise from alterations in the mtDNA but also in nuclear
genes encoding proteins required for regulation of mtDNA expression.
On one hand, mutations or deletions within one of the 2 rRNAs or 22
tRNAs encoding genes will affect the translation of the 13 mtDNA-
encoded subunits of the ETC. Such alterations lead tomitochondrial dis-
eases such as MELAS (Mitochondrial Encephalopathy, Lactic Acidosis,
and Stroke-like episodes), MERRF (Myoclonic Epilepsy with Ragged
Red Fibers) and KSS (Kearns–Sayre Syndrome) mainly associated
with mutations within tRNAleu (A3243G), tRNAlys (A8344G) or large-
scale mtDNA deletion, respectively (Goto et al., 1990; Maceluch and
Niedziela, 2006; Shoffner et al., 1990). On the other hand, the proteins
required to support mtDNA expression are encoded by the nuclear
genome (Vafai and Mootha, 2012). Therefore, it is not surprising that
an increasing number of human mitochondrial diseases have been
linked with nuclear genes encoding proteins involved in mitochondrial
protein synthesis such as tRNA-modifying enzymes, aminoacyl-tRNA
synthetases, ribosomal proteins, elongation, mRNA stability and termi-
nation factors as well as translation activators (Pearce et al., 2013).
Altered expression of mtDNA results in mitochondrial dysfunction and
perturbs cellular homeostasis as mitochondria is important not only
for ATP production by oxidative phosphorylation but also for lipid
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as well as regulation of programmed cell death. Hence, general feature
of mitochondrial diseases include reduced ATP production, decreased
membrane potential, altered calcium homeostasis and ROS production
(James et al., 1996; Lenaz et al., 2004; Moudy et al., 1995; Vives-Bauza
et al., 2006).
Coordinated expression of both genomes and communication be-
tween mitochondria and nucleus is thus critical to maintain proper cell
function. Transcriptional regulators are key players in mitochondria-to-
nucleus communication as they orchestrate the expression of nuclear
genes in response to both external challenges and organelle dysfunction
to regulate processes such as mitochondrial biogenesis, cell proliferation,
metabolism and apoptosis, as reviewed in Ryan andHoogenraad, (2007).
Some of them have very well described signaling pathways activated in
response tomitochondrial stress such as among other NFAT (nuclear fac-
tor of activated T cells), NFκB (nuclear factor kappa B) and CREB (cAMP-
responsive element binding protein) triggered by increased cytosolic cal-
cium concentration because of altered mitochondrial buffering function
(Arnould et al., 2002; Biswas et al., 1999, 2003). First andmainly reported
in the context of endoplasmic reticulum stress, the transcription factor
CHOP-10 (C/EBP homologous protein 10, also known as DDIT3 or
GADD153) has also been reported to respond to mitochondrial dysfunc-
tion. Indeed, increased expression of the transcription factor has been
demonstrated in the context of disrupted mitochondrial protein homeo-
stasis (proteostasis) (Moisoi et al., 2009; Zhao et al., 2002), inhibition of
mitochondrial ETC (Ishikawa et al., 2009; Vankoningsloo et al., 2006)
and mutation within mtDNA (Cortopassi et al., 2006; Fujita et al., 2007).
However, events and stress signaling pathways associated with mito-
chondrial dysfunction-induced CHOP-10 overexpression are not clear.
Hoogenraad and colleagues have demonstrated that CHOP-10 is regu-
lated by AP-1 in the context of the mitochondrial unfolded protein re-
sponse (mtUPR), a specific quality control process that aims to resolve
proteotoxic stress by coordinating expression of mitochondrial chaper-
ones and proteases such as HSPD1 (also known as chaperonin 60 or
HSP60) and ClpP, respectively (Horibe and Hoogenraad, 2007). Briefly,
in this model, overexpression of a truncated version of the enzyme
ornithine transcarbamylase (OTCΔ) results in its accumulation as
an unfolded proteins within mitochondrial matrix that leads to JNK
(c-Jun N-terminal Kinase) activation and phosphorylation of the AP-1
familymember c-Jun. Once translocated into the nucleus, this transcrip-
tion factor increases CHOP-10 expression that in turn triggers expres-
sion of stress responsive genes (Horibe and Hoogenraad, 2007).
Moreover, the impairment of the stoichiometric equilibrium between
nuclear and mtDNA-encoded proteins is another condition known to
induce mtUPR as suggested in rho0 cells and demonstrated for murine
cells incubated in the presence of doxycycline, an antibiotic of the tetra-
cycline family that inhibits mitochondrial translation (Houtkooper
et al., 2013; Martinus et al., 1996). So far, the global mechanism
of mtUPR is still missing in mammals as cell signaling activated by
accumulation of unfolded proteins has been mainly described in
Caenorhabditis elegans (Pellegrino et al., 2013).
However, others have shown that increased expression of CHOP-10
associated with mitochondrial respiration defect relies more on the in-
tegrated stress response (ISR) than mtUPR (Cortopassi et al., 2006;
Fujita et al., 2007; Ishikawa et al., 2009; Moisoi et al., 2009). ISR is a sig-
naling pathway converging to eIF2α phosphorylation and characterized
by a global reduction in protein synthesis, together with a selective
overexpression of stress-responsive genes (Fujita et al., 2007; Silva
et al., 2009). ISR sensors consist of a set of four different kinases: PERK
(PKR-like ER-kinase), GCN2 (general control non-derepressible-2),
HRI (heme-regulated inhibitor) and PKR (protein kinase double-
stranded RNA-dependent). These four kinases are activated in response
to various cues such as endoplasmic reticulum stress, amino acid
depletion, viral infection, oxidative stress, heme deprivation, UV irradi-
ation and proteasome inhibition (Donnelly et al., 2013; Harding et al.,
2000, 2003). Even if eIF2α phosphorylation reduces cytosolic proteinsynthesis, mRNAs containing short upstream open reading frames are
preferentially translated, such as ATF4, ATF3 and CHOP-10 (Wek et al.,
2006). The latter is a pleiotropic transcription factor that is associated
with cell death/survival under ER stress as it can either trigger or
prevent apoptosis (Fujihara et al., 2009; Zinszner et al., 1998). In addi-
tion to its expression level, CHOP-10 can be regulated by post-
transcriptional modifications such as phosphorylation by p38 or CK2
(casein kinase 2), resulting in an enhanced or attenuated transcriptional
activity, respectively (Ubeda and Habener, 2003;Wang and Ron, 1996).
Together with other transcription factors of the bZIP family, ATF4
and CHOP-10 regulate the expression of specific stress genes such
as the ERAD (endoplasmic-reticulum-associated protein degradation)-
associated protein HERP (homocysteine-inducible, endoplasmic reticu-
lum stress-inducible, ubiquitin-like domainmember 1) and the pseudo-
kinase Trib3 (tribble 3) (Harding et al., 2003; Kilberg et al., 2009).
In this study, as CHOP-10 can be activated by both mtUPR and ISR,
we analyzed the regulation of CHOP-10 expression in different cell
models in which mtDNA expression is impaired, such as mitochondrial
genome depletion and translation inhibition, to better understand sig-
naling pathways triggered by mitochondrial dysfunction that could
converge to the activation of this transcription factor. The investigation
of these stress signaling pathways might help to better characterize
mitochondrial diseases associated with mtDNA depletion or impaired
organelle translation.
2. Materials and methods
2.1. Cell culture, transfection and reagents
The HeLa adenocarcinoma and Hep3B hepatocellular carcinoma cell
lines were purchased from ATCC (CCL-2 and HB-8064, respectively).
HeLa rho0 cells were a kind gift of Professor R.Wiesner (University of Co-
logne, Germany). HeLa cells were grown in Minimum Essential Media
(MEM, Gibco) supplemented with pyruvate (11360-039, Gibco), non-
essential amino acid (11140-035, Gibco) and 10% of fetal calf serum
(FCS) (Gibco). HeLa rho0 cells were grown in 4.5 g/l glucose-containing
Dulbecco's modified Eagle Medium (DMEM, Gibco) supplemented
with pyruvate, non-essential amino acid, 10% of fetal calf serum and
50 μg/ml uridine. Hep3B cells were cultured in Roswell Park Memorial
Institute medium (RPMI 1640 Invitrogen, 21875) containing 10% of FCS.
Fresh human hepatocytes (HEP220)were obtained from Biopredic inter-
national and kept in medium for long-term culture (MIL600C) supple-
mented with additive (ADD27111C). All cell lines were kept at 37 °C
under a humidified atmosphere containing 5% CO2. Stock solution of
doxycycline (Sigma, D9891-1G) was prepared in deionized water at a
concentration of 15 mg/ml, filter sterilized and used at a final concentra-
tion of 15 or 30 μg/ml as indicated.
For reporter gene experiments, HeLa cells have been transfected
with SuperFect transfection reagent from Qiagen (301305). Briefly,
cells were seeded one day before transfection in 12-well plates
(50,000 cells/well). Cells were transiently transfected with 0.6 μg of a
Firefly luciferase reporter plasmid and 0.4 μg of a plasmid containing a
cDNA encoding Renilla luciferase under the control of the TK promoter
(pRenillaLuc-TK), used for normalization. The DNA/SuperFect ratio was
1:2 and cells were incubated with complexes for 3 h in the absence of
serum before refreshing with new medium, containing doxycycline or
not, for 48 h.
For silencing experiments, On-target plus siRNA smartpools
purchased from Dharmacon were used: ATF4 (L-005125-00-0005),
PERK (L-004883-00-0005), GCN2 (L-005314-00-0005), HRI (L-005007-
00-0005), PKR (L-003527-00-0005). Non-targeting On-target plus
siRNA (D-001810-10-05) have been used as negative control. 200,000
cells were seeded in 6-well plates in complete growth medium. The
next day, cells were transfected with 50 nM siRNA diluted in opti-MEM
(Gibco, 31985-070) and using Dharmafect 1 (T-2001-01) as transfection
reagent, following the manufacturer's recommendation. After 24 h of
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diumwas replacedwith complete culturemedium for another 24 h. Cells
were then incubatedwith doxycycline or controlmedium for the indicat-
ed time.
2.2. Luciferase reporter assay
The pCHOP-10_luc constructs, a kind gift of Dr. Vaandrager (Utrecht
University, Nederland's), consist of the pGL3 basic plasmid with the
−442 to+91 human CHOP-10 promoter region fused to the luciferase
gene. The reporter plasmids contain either wild-type or mutated
sequences within the AARE (amino acid responsive element), AP-1 or
ERSE (endoplasmic reticulum stress element) binding sites as fully
described in van der Sanden et al. (2004). Reporter gene assay was per-
formed using the dual-luciferase reporter assay from Promega (E1910)
and following manufacturer's recommendation. Luminescence was
measured using Lucetta luminometer (Lonza, AAL-1001) and Firefly
activity was normalized to Renilla activity.
2.3. Real-time RT-qPCR
Cells were scraped in RLT lysis buffer and total RNA was prepared
using the RNeasy mini kit from Qiagen (74104). An optional on-
column DNase (79254, Qiagen) digestion of 15 min incubation step
was performed to prevent any co-purification of DNA along with RNA.
Complementary DNA was synthesized from 2 μg of total RNA and with
oligoT primers using the Transcriptor First Strand cDNA Synthesis kit
from Roche (04896866001). Real-time PCR analysis was performed on
the StepOneplus system fromApplied Biosystemusing FastStart Univer-
sal SYBR Green Master mix (04913914001, Roche) and specific primers
at a final concentration of 300 nM in a volume of 25 μl. Primerswere de-
signed, using the online primer blast software, to evaluate mRNA abun-
dance of the following targets: CHOP-10 forward: 5′-GCAAGAGGTCCT
GTCTTCAGATG-3′ and reverse: 5′-CTCAGTCAGCCAAGCCAGAGA-3′;
HSPD1 forward: 5′-TGATGCTATGGCTGGAGATTT-3′ and reverse: 5′-
ACACCAGCAGCATCCAATAA-3′; ClpP forward: 5′-GTTGCCAGCCTTGTTA
TCG-3′ and reverse: 5′-TGCATCGTGTCGTAGATGG-3′; Trib3 forward:
5′-CGTGATCTCAAGCTGTGTCG-3′ and reverse: 5′-AGCTTCTTCCTCTCAC
GGTC-3′; ATF3 forward: 5′-GGAGCCTGGAGCAAAATGATG-3′ and re-
verse: 5′-AGGGCGTCAGGTTAGCAAAA-3′; HERP forward: 5′-ATTTAG
ACCGAGGCCGGTTC-3′ and reverse: 5′-CAGGATCAGTGCCTTCCTGTA-3′;
PPIE forward: 5′-TCATGCTGCGTTCATTCCTT-3′ and reverse: 5′-GCTC
AGATTCATTCATGTTGTCG-3′. PCR program started with 5 min at 95 °C
followed by 40 cycles at 95 °C for 15 s and 60 °C for 1 min. A melt
curvewas added at the end of the PCR to check intended product ampli-
fication. PPIE was used as a reference gene for normalization andmRNA
expression level was quantified using the threshold cyclemethod as de-
scribed in (Livak and Schmittgen, 2001).
2.4. Western blotting analysis
For protein extraction, cells were kept on ice and scraped in lysis
buffer (20 mM Tris, pH 7.4; 150 mM KCl, 1 mM EDTA and 1% Triton
X-100) complemented with protease inhibitor cocktail (complete from
Roche) and phosphatase inhibitor mixture (1 mM NaVO3, 10 mM
p-nitrophenyl phosphate, 10 mM β-glycerophosphate and 5 mM NaF).
Clear lysates were retrieved from the supernatant of cell lysates after a
10 min centrifugation at 13,000 rpm at 4 °C and protein concentration
was determined using the Pierce 660 nmProtein Assay (Thermo scientif-
ic, 22660).
For western blotting analysis, 15 to 20 μg of proteins were loaded on
4–15% Mini-PROTEAN TGX precast gel (Bio-rad #456-1086) or 3–8%
Tris–Acetate gel (NuPAGE, Life technologies #EA0375BOX) and re-
solved by electrophoresis in Tris–Glycine or Tris–Acetate runningbuffer,
respectively. Proteins were transferred onto a low-fluorescence PVDF
membrane (Immobilon FL, Merck-Millipore), blocked in Li-cor Odysseyblocking buffer (927–40,000) diluted in PBS and incubated with appro-
priate primary and secondary antibodies diluted in Odyssey blocking
buffer supplemented with 1% Tween. Proteins were revealed using the
infrared fluorescence Odyssey scanner (Li-cor). Protein abundance was
evaluated using the following primary antibodies: COXI (Ab14705,
Abcam), COXII (AbAA0258, Abcam), COXIV (A21348, Life Technolo-
gies), CHOP-10 (ALX-804-551-C100, Enzo Life Sciences), P-eIF2α
Ser51 (3795S, Cell signaling), eIF2α (9722S, Cell signaling), HSPD1
(SAB1405973-50UG, Sigma), TOM40 (sc-11414, Santa-cruz), α-tubulin
(T5168, Sigma) and corresponding secondary antibodies coupled to
infrared dyes (IRdye, Li-cor).
2.5. Statistical analysis
Data from at least three independent experiments are presented as
means ± S.D. and have been analyzed using the Sigma-stat software
with the appropriate statistical test such as ANOVA-I or ANOVA-II
followed by a Holm–Sidak post-test. Differences between means were
only considered as statistically significant when p b 0.05 or less. For
some experiments, when normality test failed, data have been trans-
formed into logarithmic values.
3. Results
3.1. Mitochondrial dysfunction triggers CHOP-10 overexpression
As few studies have described the induction of CHOP-10 upon differ-
ent kinds of mitochondrial dysfunction (Cortopassi et al., 2006; Fujita
et al., 2007; Ishikawa et al., 2009; Moisoi et al., 2009), we first assessed
CHOP-10mRNA abundance in two differentmodels of impairedmtDNA
expression. First, we used rho0 cells, an extensively described and useful
model to study OXPHOS defect and retrograde signaling induced by
mtDNA depletion (Chandel and Schumacker, 1999; Mercy et al., 2005;
Mineri et al., 2009; Miranda et al., 1999). The mRNA abundance of
CHOP-10 assessed by RT-qPCR indicates that the abundance of CHOP-
10 mRNA is significantly increased in rho0 HeLa cells when compared
with their wild-type counterpart (Fig. 1A). This result has been con-
firmed in HeLa cells incubated with ethidium bromide (EtBr), an inter-
calating agent known to inhibit mtDNA transcription and replication
and to be responsible for a progressive dilution and depletion of mito-
chondrial genome as cells divide (Seidel-Rogol and Shadel, 2002). A
15 day-treatment with 50 ng/ml ethidium bromide strongly decreases
the relative copy number of mtDNA (Fig. S1A) that is associated with
an increase in CHOP-10 mRNA abundance suggesting that CHOP-10
induction in mtDNA-depleted cells is not just a clone effect or a result
of long term cell adjustment but an early response observed in cells fac-
ing a reduction of mtDNA content (Fig. S1B).
As a second cell model of impaired mitochondrial genome expres-
sion, we used doxycycline. In bacteria, doxycycline is well known to
interfere with the binding of the amino-acylated tRNA to the mRNA,
thus inhibiting translation (Chopra et al., 1992). In line with the
α-proteobacteria origin of mitochondria, such antibiotic has been de-
scribed to inhibit mitochondrial translation (van den Bogert et al.,
1986). As decreased abundance of mtDNA-encoded proteins is there-
fore expected in doxycycline-treated cells, we first assessed the steady
state level of COXI and COXII, by western blot, in HeLa cells incubated
for 24, 48, or 72 h in the presence of 15 μg/ml of the antibiotic. A de-
crease in the abundance of COXI and COXII is observed as early as
after 24 h of incubation, and is even more pronounced after 48 and
72 h, while the level of the nuclear-encoded protein TOM40 stays un-
changed (Fig. 1B). As for the rho0 cell model, the mitochondrial impair-
ment provoked by doxycycline is accompanied by a time-dependent
increase in CHOP-10 mRNA abundance that reaches a 20 fold-
induction after 72 h of treatment (Fig. 1C). The induction of CHOP-10
expression in response to doxycycline was reflected at the protein
level as illustrated at Fig. 1D. To rule out unspecific effect of doxycycline,
A C
B
D
Fig. 1. Disruption of mtDNA expression increases CHOP-10 expression in HeLa cells. CHOP-10 has been studied in 2 different models of impaired protein synthesis within mitochondria.
(A) CHOP-10mRNAabundance has been evaluated by RT-qPCR inHeLa cells totally depleted ofmtDNA (rho0) and compared towild-type (WT) cells. (B) Doxycycline-mediated inhibition
ofmitochondrial translation efficiencywasmonitored bywestern blot analysis of the abundance of COXI and COXII, 2 mtDNA-encoded proteins, and TOM40 used as a control for nuclear-
encoded proteins. HeLa cells have been incubatedwith control or 15 μg/ml doxycycline (DOX) containingmedium during 24, 48 or 72 h. Immunodetection of tubulinwas used as loading
control. To highlight themito-nuclear protein imbalance triggered by doxycycline, on the right of the graph is presented thewestern blot quantifications and expressed as the ratio of COXI
or COXII to TOM40, all normalized to their respective tubulin. (C) CHOP-10 mRNA abundance has been studied by RT-qPCR in HeLa cells incubated with control medium (CTL) or with
medium containing 15 μg/ml doxycycline (DOX) for 24, 48 or 72 h as well as (D) at the protein level by western blot analysis for the last two time points. Western blot quantification
using the Odyssey software is represented at the right for CHOP-10 abundance normalized to lamin β used as the loading control. Results represent means ± 1 SD for 3 independent
experiments and are expressed as fold change compared to WT (A) and CTL 24 h (C). **: p b 0.01 and ***: p b 0.001.
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24 hwith chloramphenicol, another antibiotic described to inhibitmito-
chondrial translation in mammals (Balbi, 2004). A strong CHOP-10
induction was also obtained for cells incubated with the antibiotic
(Fig. S2A).
3.2. Impairment of mtDNA expression does not trigger the mitochondrial
unfolded protein response but activates the integrated stress response
CHOP-10 is known to be associated with the unfolded protein re-
sponse of the endoplasmic reticulum (erUPR) (Schroder and Kaufman,
2005). However, more than 10 years ago, Hoogenraad and colleagues
already reported that CHOP-10 is also activated in a mitochondria-
specific unfolded protein response (mtUPR) (Zhao et al., 2002). Still, if
some mechanisms of mtUPR have been recently described in C. elegans
(Pellegrino et al., 2013), the mammalian counterpart is less defined.
In addition, among the different gene markers that are potentially
overexpressed in response to mtUPR in mammals such as the protease
YME1L1, MPPβ and the endonuclease G (Aldridge et al., 2007), only
genes encoding ClpP and HSPD1 have been consistently assessed in
subsequent studies dealing with mito-nuclear protein imbalance
(Houtkooper et al., 2013; Mouchiroud et al., 2013). As disrupting
mtDNA expression leads to depletion of proteins encoded by the mito-
chondrial genome, we thus studied the putative activation of mtUPR by
assessing the relative mRNA abundance of ClpP and HSPD1 using
RT-qPCR. Unexpectedly, ClpP expression is strongly repressed in rho0
HeLa cells when compared with wild-type counterpart while there isno significant difference for HSPD1 between mtDNA-depleted and
wild-type HeLa cell lines (Fig. 2A). Similarly, there is no induction of
the mtUPR-responsive ClpP and HSPD1 genes in EtBr-treated HeLa
cells (Fig. S1C). The abundance of those two mtUPR markers has also
been assessed in doxycycline- (Fig. 2B and C) and chloramphenicol-
(Fig. S2B) treated HeLa cells, but there is neither induction of the mito-
chondrial protease nor the chaperone at the transcript level. Results ob-
tained at the mRNA level have been confirmed at the protein level for
HSPD1 abundance but no change was observed in doxycycline-treated
HeLa cells when compared with untreated control cells (Fig. 2D).
Based on the two main markers used to characterize mtUPR activa-
tion, the data shows that CHOP-10 induction is not associated with this
specific stress pathway in the different models of impaired mitochon-
drial DNA expression tested, corresponding tomtDNAdepletion or inhi-
bition of mitochondrial translation. As previously mentioned, CHOP-10
is also induced during the ISR, thus, to answer the question whether
impaired mtDNA expression could trigger this stress response, the
mRNA abundance of Trib3, ATF3 and HERP was assessed by RT-qPCR
(Harding et al., 2003; Kilberg et al., 2009). As illustrated in Fig. 3A, the
transcript abundance of these three ISR markers is increased in rho0
when compared with wild-type HeLa cells (Fig. 3A) and in EtBr-
treated HeLa cells (Fig. S1D). Trib3 and ATF3 are also overexpressed in
HeLa cells incubated with doxycycline in a time–dependent manner
and HERP mRNA is also significantly more abundant in cells treated
with doxycycline for the three time points studied (Fig. 3B). As for
CHOP-10, the mRNA abundance of these three genes is also increased
in HeLa cells incubated for 24 h with chloramphenicol (Fig. S2C).
AC
D
B
Fig. 2. Impairingmitochondrial protein synthesis inHeLa cells does not increase expression of genes associatedwith themitochondrial unfoldedprotein response. (A)mRNA abundance of
the two mtUPR-associated protein markers ClpP and HSPD1 was evaluated by RT-qPCR in rho0 HeLa cells compared to wild-type counterpart. The abundance of ClpP (B) and HSPD1
(C) mRNA was assessed by RT-qPCR in HeLa cells incubated in control medium (CTL) or in the presence of 15 μg/ml doxycycline (DOX) for 24, 48 or 72 h. Results are presented as
means± 1 SD for three independent experiments and are expressed as fold change toWT (A) or CTL 24 h (B, C) and ***: p b 0.001. (D) Protein level of HSPD1was determined bywestern
blot analysis in HeLa cells incubatedwith or without 15 μg/ml doxycycline for 24, 48 or 72 h. Tubulin is used as a loading control. The quantification of HSPD1 protein abundance normal-
ized to tubulin abundance is shown at the right of the chart.
A
B
Fig. 3. Interfering with mtDNA expression in HeLa cells triggers the integrated stress response. mRNA abundance of ISR-related gene markers Trib3, ATF3 and HERP was assessed by RT-
qPCR in HeLa cells totally depleted of mtDNA (A) and in HeLa cells incubated with control medium or supplemented with 15 μg/ml doxycycline for 24, 48 and 72 h (B). Results are
expressed as fold change to WT cells (A) or control 24 h (B) and represent means for 3 independent experiments. *: p b 0.05, **: p b 0.01 and ***: p b 0.001.
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63S. Michel et al. / Mitochondrion 21 (2015) 58–68Despite the use of different models in which mtDNA expression is
altered, we were thus unable to evidence an induction of mtUPR
markers. In view of these unexpected results and even if they have
also been confirmed in breast cancer MCF7 cells (Fig. S3A and B), we
next questioned the cell models studied. Indeed, although cancer cell
lines represent a very useful tool, their nuclear gene expression back-
ground is often altered when compared with their healthy counterpart.
Thus, we next compared the effect of doxycycline treatment in trans-
formed versus primary human hepatocytes to validate the results
obtained. The hepatocellular carcinoma-derived Hep3B cells were incu-
bated with 15 μg/ml doxycycline for 24, 48 or 72 h. The doxycycline ef-
ficiency was first checked by western blot analysis of COXI and COXII
protein abundance. In these conditions, comparable results to HeLa
cells were obtained: the COXI/TOM40 and COXII/TOM40 ratio decreases
after 24 h of incubation of Hep3B cells with the antibiotics (Fig. S4A).
The mRNA abundance of CHOP-10, ClpP, HSPD1, Trib3, ATF3 and HERP
was then assessed in the same experimental conditions (Fig. 4A). First,
CHOP-10 expression is induced already after 24 h of treatment of
Hep3B cells. Second, the levels of ClpP and HSPD1 mRNA were either
unchanged or decreased regardless of the duration of incubation withA
B
C
Fig. 4. Doxycycline triggers expression of genes associated with the integrated stress respons
(A) mRNA abundance of CHOP-10, mtUPR-related ClpP and HSPD1 and ISR-induced Trib3, ATF
(CTL) or 15 μg/ml doxycycline-supplemented (DOX) medium for 24, 48 or 72 h. Results are
*; **; ***: p b 0.05; 0.01; and 0.001, respectively. (B) Human primary hepatocytes were incubate
Results are expressed as fold change to corresponding CTL and representmeans of 2 independe
hepatocytes incubated with doxycycline (15 or 30 μg/ml) during 24 or 48 h.doxycycline. Third, the abundance of Trib3, ATF3 and HERP is increased
in doxycycline-treated Hep3B cells after a 24, 48 or 72 h-treatment
when compared with untreated cells. A comparable experiment was
conducted in primary human hepatocytes that have been incubated
with doxycycline at 15 or 30 μg/ml during 24 or 48 h and results
are illustrated in Fig. 4B. As for cancer cells lines, CHOP-10mRNA abun-
dance increases in a time and concentration–dependent manner in
treated hepatocytes when comparedwith untreated cells.While no dif-
ference between control and doxycycline-treated hepatocytes is detect-
able regarding ClpPmRNA, there is a slight but time- and concentration-
dependent increase in HSPD1 mRNA (up to 2 fold-increase in cells
incubated for 48 h with doxycycline at 30 μg/ml). However, the
up-regulation of HSPD1 could not be reflected at the protein level as
illustrated at Fig. 4C. Finally, Trib3 and ATF3 mRNA are both induced
in hepatocytes treatedwith doxycyclinewhereas HERP transcript abun-
dance is only barely increased when compared with control cells. Even
if the intensity of induction of the different ISR markers in response
to doxycycline varies depending on the cell type, these results show
that ISR activation in response to mitochondrial translation inhibition
is not only restricted to cancer cells but is also observed in primarye but not the mitochondrial unfolded response in both cancer and primary hepatocytes.
3 and HERP was evaluated by RT-qPCR in Hep3B cells. Cells were incubated with control
expressed as fold change to CTL 24 h as means ± 1 SD for 3 independent experiments.
d 24 or 48 h with control (CTL) or doxycycline containing (15 or 30 μg/ml, DOX)medium.
nt experiments. (C) HSPD1 protein abundance assessed bywestern blot in human primary
64 S. Michel et al. / Mitochondrion 21 (2015) 58–68human cells such as hepatocytes. However, it is important to point out
that COXI and COXII abundance is kept unchanged in doxycycline-
treated hepatocytes (Fig. S4B), which could explain the non-induction
of mtUPR markers in this cell type. Most importantly, this result ques-
tions the triggering event of ISR activation, since the latter is observed
without mito-nuclear imbalance. It can be hypothesized that either
the mito-nuclear protein imbalance is not at the origin of the stress
response or it involves an alternative stress-signaling mechanism in
primary hepatocytes that also leads to ISR activation. Altogether, the ex-
periments performed in Hep3B cells and primary human hepatocytes
incubated with doxycycline confirmed the results obtained with HeLa
cells showing the induction of ISR-related targets such as CHOP-10,
Trib3 and ATF3.
3.3. Doxycycline-induced eIF2α phosphorylation is mediated by GCN2
To confirm these results and the activation of ISR, we also analyzed
the phosphorylation status of eIF2α in a time-course experiment. As
shown in Fig. 5A, eIF2α is phosphorylated in cells incubated with doxy-
cycline as soon as after 1 h of treatment and the post-translational
modification is still observed for longer incubation time up to 18 h of
treatment. We next aimed to identify the kinase upstream eIF2α phos-
phorylation. So far, four serine–threonine kinases have been described
to phosphorylate eIF2α: PERK, GCN2, PKR and HRI (Donnelly et al.,
2013). First, we checked the silencing efficiency of siRNA for the kinases.
After 48 h of transfection, the protein level of the siRNA-targeted PERK,
GCN2 and PKR in HeLa cells is reduced below 20% when compared
to control cells, without affecting the level of the other kinases
(Fig. S5A-B). Although, we were not able to assess the silencing effi-
ciency of HRI at the protein level, due to the poor quality of the antibod-
ies, a strong decrease (97% decrease) was observed on the abundance
of the HRI transcript, a data compatible with a down-regulation of the
kinase at the protein level (Fig. S5C). In these experimental conditions
of silencing, the level of eIF2α phosphorylation in doxycycline-treated
HeLa cells was assessed by western blot (Fig. 5B). In the absence of
doxycycline, the level of eIF2α phosphorylation is quite comparableB
A
Fig. 5. Doxycycline-induced eIF2α phosphorylation in HeLa cells is dependent on the GCN2 kin
periment in HeLa cells incubated with or without doxycycline at 15 μg/ml during 1 up to 18
immunodetection of tubulin was used as a loading control. (B) HeLa cells were not transfected (
eIF2α: PERK (siPERK), GCN2 (siGCN2), HRI (siHRI) and PKR (siPKR), as well as with non-targe
doxycycline-containing medium for 1 h. Phosphorylated and total eIF2α abundance was assess
right is shown the quantification of P-eIF2α represented as the ratio of P-eIF2α to eIF2α, both no
non-transfected HeLa cells incubated with control medium (CTL NT). The result is the represenbetween the different conditions, excepted in the presence of siRNA
against GCN2 and HRI that reduces the phosphorylation of eIF2α. In
doxycycline-treated HeLa cells, the level of eIF2α phosphorylation
increases in all conditions except when GCN2 abundance is reduced, a
result suggesting that the kinase that phosphorylates eIF2α in cells
treated with doxycycline is GCN2.3.4. ATF4 triggers CHOP-10 induction in doxycycline-treated HeLa cells
To further understand CHOP-10 transcriptional regulation upon mi-
tochondrial dysfunction, we next determined the putative contribution
of three well-described cis-acting elements within its promoter: the ER
stress responsive element (ERSE, −104/−75, (Ubeda and Habener,
2000)), the AP-1 binding site (−250/−225, (Guyton et al., 1996))
and the amino acid responsive element (AARE,−313/−295, (Bruhat
et al., 1997)). A reporter plasmid containing the luciferase gene under
the control of the CHOP-10 promoter region, spanning from nucleotides
−442 to+91, that is either wild-type ormutated for one of these three
regulatory sequenceswas used (van der Sanden et al., 2004) and is illus-
trated on the left of Fig. 6A. First, a 48 h-incubation of HeLa cells with
doxycycline increases reporter activity in cells transiently transfected
with the plasmid containing the wild-type sequence of the CHOP-10
promoter, a data in agreement with the results shown for the endoge-
nous mRNA and protein levels (Fig. 1). Second, mutation of either the
ERSE or the AP-1 binding site has no drastic effect on the reporter activ-
ity. By contrast, the luciferase activity induced in response to doxycy-
cline is strongly reduced when the AARE binding site is mutated
(Fig. 6A), suggesting the requirement for ATF4 activation in the
doxycycline-induced CHOP-10 expression, as ATF4 is well known to
bind to the AARE (Averous et al., 2004). In addition, increased ATF4
abundance is consistent with the doxycycline-induced phosphorylation
of eIF2α (Fig. 5) as eIF2α is known to trigger preferential ATF4 translation
(Vattem andWek, 2004). Indeed, ATF4 protein abundance increases in a
time–dependentmanner in HeLa cells treatedwith 15 μg/ml doxycycline
while being undetectable in control cells (Fig. 6B).ase. (A) The level of eIF2α phosphorylation has been evaluated during a time-course ex-
h. Both phosphorylated and total eIF2α abundance were assessed by western blot and
NT) or transfected with siRNA against each of the four kinases described to phosphorylate
ting siRNA (siNT). After 48 h of transfection, cells were incubated with control or 15 μg/ml
ed by western blot and immunodetection of tubulin was used as a loading control. On the
rmalized to their respective loading control. Results are finally expressed as fold change to
tative of three independent experiments.
AB
C D
Fig. 6. ATF4 triggers CHOP-10 induction in doxycycline-treated HeLa cells. (A) Reporter plasmid assay using a fragment of the CHOP-10 promoter sequence (−442 to +91) upstream of
the Firefly luciferase gene. 24 h post-transfectionwith the reporter and normalization plasmids, HeLa cells were incubatedwith orwithout (control: CTL) 15 μg/ml doxycycline containing
medium (DOX) for 48 h before assessing reporter activity. Promoter sequence of the reporter plasmid contains either wild-type (WT) ormutated sequence for one of the three following
cis-acting elements: ER stress response element (ERSE), AP-1 binding site (AP-1) or the amino acid responsive element (AARE) site as illustrated on the left panel. Firefly luciferase activity
was normalized to Renilla luciferase activity and expressed as fold change to respective control. (B) ATF4 protein level evaluated by western blot. HeLa cells were incubatedwithmedium
containing or notwith 15 μg/ml doxycycline (DOX) for 6, 12 or 18h. Immunodetection of tubulinwas used as the loading control. The graph on the right represents ATF4 abundance quan-
tification normalized to tubulin and expressed as fold change compared to HeLa cells incubated for 6 h in control medium. (C) Impact of ATF4 silencing on increased doxycycline-induced
CHOP-10 and Trib3mRNAabundance.HeLa cellswere either not transfected (NT), transfectedwith non-targeting siRNA (siNT) or siRNA against ATF4 (siATF4) during 24h beforemedium
renewal and incubation for 48 hwith control (CTL) or 15 μg/ml doxycycline supplementedmedium (DOX). Results are expressed as fold change to no-transfected (NT) CTL and represent
means ± 1 S.D. of three independent experiments. *: p b 0.05 and ***: p b 0.001.
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10 expression was finally confirmed thanks to ATF4 silencing by
siRNA. While transfection with non-targeting siRNA slightly increases
CHOP-10 expression, silencing of ATF4 strongly decreases the abun-
dance of CHOP-10 in HeLa cells treated for 24 h with doxycycline
(Fig. 6C).We further checked the involvement of ATF4 in the expression
of other ISR target genes such as Trib3. As shown in Fig. 6D, Trib3 induc-
tion is completely prevented when cells are transfected with siRNA
against ATF4 while still robustly overexpressed in the non-targeting
siRNA condition.
4. Discussion
The integrated stress response (ISR) is a stress response pathway
based on four kinases that regulate eIF2α phosphorylation and gene ex-
pression in response to broad types of cues, such as extensively de-
scribed for endoplasmic reticulum stress and amino acid starvation
(Donnelly et al., 2013). In this study, we have shown that disrupting
mtDNA expression activates the ISR (Fig. 7). Indeed, either depletion
or inhibition of mtDNA expression in HeLa cells increases expression
of ISR-responsive genes such as the transcription factors CHOP-10 and
ATF3, the pseudo kinase Trib3 and the ERAD-associated protein HERP
(Figs. 1A, C, D, 3A and B). CHOP-10 and Trib3 inductions are dependent
on the central transcriptional regulator ATF4 as demonstrated bysilencing experiments (Fig. 6C and D). Consistent with the observed
eIF2α phosphorylation, the protein abundance of ATF4 is increased
when cells are incubated with doxycycline, an antibiotic that inhibits
mitochondrial translation (Figs. 5A and 6B). Increased expression of
these targets has also been confirmed in human primary hepatocytes
(Fig. 4B) as well as in Hep3B (Fig. 4A) and MCF7 cells (Fig. S3).
Surprisingly, in doxycycline-treated hepatocytes, the protein abun-
dance of COXI and COXII (Fig. S4B), both mtDNA-encoded proteins, is
not decreased as observed in HeLa (Fig. 1B) and Hep3B (Fig. S4A)
cells, suggesting that depletion of mtDNA-encoded ETC subunits is not
the triggering event of ISR activation per se. A very recent study showed
that ATF4, ATF3 and CHOP-10 are overexpressed in cells incubated with
tetracyclines (Bruning et al., 2014). Doxycycline belongs to this class of
antibiotics that, in addition to mitochondrial translation inhibitor, are
also known as bivalent ions chelators. Bruning and colleagues attributed
some of the observed effects to magnesium depletion (Bruning et al.,
2014). However, mitochondrial translation impairmentwith other clas-
ses of antibiotics such as actinonin, the peptide deformylase inhibitor, in
mouse embryonic fibroblasts (MEFs) also rapidly (and in a sustained
manner) induces CHOP-10, Trib3 and ATF3 overexpression (Richter
et al., 2013). Together with the results obtained in rho0 cells (Figs. 1A
and 3A) as well as for cells treated with chloramphenicol (Fig. S2)
or ethidium bromide (Fig. S1), these results suggest that the ISR is trig-
gered by the doxycycline-induced disruptedmtDNA expression and not
Fig. 7.Hypotheticalmodel for stress response tomitochondrial dysfunction. In response to
mitochondrial dysfunction such as mtDNA depletion and inhibition of mitochondrial
translation, the GCN2 kinase is activated. In turn, the kinase phosphorylates eIF2α that
has at least 2 consequences. While the cytosolic translation is globally attenuated,
mRNAs containing an uORF are preferentially translated such as the transcription factors
ATF4 and CHOP-10. The profit of this GCN2-eIF2α-ATF4 pathway might be stress attenua-
tion by relieving the load of protein imported into mitochondria but also by increasing the
expression of stress responsive genes. Dashed lines represent a hypothetical link.
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kinase is required for eIF2α phosphorylation in response to mitochon-
drial translation inhibition in HeLa cells incubated with doxycycline
(Fig. 5B). The mechanism of GCN2 activation in response to impaired
mitochondrial translation is still unknown but, as suggested by results
in primary human hepatocytes, it is unlikely to be triggered by the
mito-nuclear protein imbalance. This idea is reinforced by the fact
that eIF2α phosphorylation is rapidly observed in response to doxycy-
cline treatment (after 1 h of doxycycline incubation) while the mito-
nuclear imbalance observed in HeLa cells requires at least 24 h of
incubation with doxycycline (data not shown). The best-described
mechanism of GCN2 activation is related to amino acid depletion and
requires the binding of an unloaded tRNA to the His-tRNA synthetase-
like and CTD (C-terminal dimerization and ribosome binding site) do-
mains of the kinase (Castilho et al., 2014). On the other hand, although
the molecular mechanism is missing, GCN2 activation is also reported
under proteasome inhibition in several studies (Acharya et al., 2009;
Jiang andWek, 2005; Neznanov et al., 2008). Interestingly, the concen-
tration of 15 amino acids and the proteasomal activity are both de-
creased in 143B cybrid cells harboring a 7.5 kb mtDNA deletion and in
lymphoblasts from patients carrying a 5 kb mtDNA deletion (Alemi
et al., 2007). In addition, in the yeast Saccharomyces cerevisiae, oxidative
stress, such as incubation with peroxide hydrogen, also activates GCN2
by a still unclearmechanism requiring the His-RS-like domain of the ki-
nase (Mascarenhas et al., 2008). Besides, induction of the GCN2-eIF2α
axis is associated with mitochondrial ETC defect in the C. elegans clk-1
(required for ubiquinone synthesis) mutant strain, which can be
prevented by NAC treatment (Baker et al., 2012). Thus, it would be
interesting to further investigate both the involvement of amino acid
depletion, proteasome inhibition, as well as ROS production in GCN2
activation upon doxycycline treatment.
In mammals, the mitochondria-specific unfolded protein response
(mtUPR) is currently accepted as a quality control relying on a retrograde
signaling to coordinate expression of specific genes, such as the chaper-
one HSPD1 and the protease ClpP, to resolve organelle proteotoxic stress
(Pellegrino et al., 2013). Different cell models have been described
to induce mtUPR: either the accumulation of protein aggregates in themitochondrial matrix, caused by the OTCΔ overexpression (Rath et al.,
2012; Zhao et al., 2002), or an imbalance between mitochondrial and
nuclear-encoded proteins, as shown in mouse hepatocytes treated with
doxycycline (Houtkooper et al., 2013) or in mtDNA depleted (rho0) rat
hepatoma cells (Martinus et al., 1996). Even if it is known that sensitivity
and response to drugs might differ between rodent and human hepato-
cytes (Black et al., 2012; Kotokorpi et al., 2007; Seok et al., 2013), in our
hands, similar stresses increase neither HSPD1 nor ClpP expression
despite testing four different models, of which one in three cancer
cell lines as well as in primary human hepatocytes (Figs. 2A, B, C, D,
S1C, S2B). However, in the later case, the non-induction of mtUPR
markersmight be the result of the absence ofmito-nuclear protein imbal-
ance as suggested by the steady-state protein level of COXI and COXII
(Fig. S4B).
In the mtUPR context provoked by OTCΔ overexpression, CHOP-10
induction would be regulated by the AP-1 transcription factor after
c-jun phosphorylation by JNK and/or PKR (Horibe and Hoogenraad,
2007; Rath et al., 2012). In the present study, even if CHOP-10 is
overexpressed, reporter plasmid experiments clearly demonstrate
that, when mitochondrial translation is inhibited by doxycycline,
the AARE binding site is required for increased transcription of the
luciferase reporter gene under the control of a region of the CHOP-10
promoter whereas mutation within the AP-1 binding site has no effect
(Fig. 6A). In addition, we confirmed ATF4 requirement as silencing of
this transcription factor prevents CHOP-10 induction by doxycycline.
Actually, a careful analysis of the literature reveals previous reports
in linewith our results showing no induction ofmtUPR uponmitochon-
drial dysfunction. First, a study from Piechota and colleagues also ana-
lyzed the impact of mitochondrial genome expression inhibitors in
HeLa cells and showed that a six-day-treatmentwith ethidiumbromide
or thiamphenicol (a derivative of chloramphenicol) does not increase
HSPD1 abundance (Piechota et al., 2006). Second, a recent in vivo
study conducted on mice KO for DARS2 (mitochondrial aspartyl-tRNA
synthetase) in cardiac and skeletal muscle tissues highlights a tissue-
specific response to mitochondrial translation impairment: no mtUPR
marker is observed in skeletal muscle, while a weak induction of HSP60
and no modification of ClpP abundance are observed in cardiomyocytes
(Dogan et al., 2014). Third, in the extensive expression profiling by
Cortopassi and colleagues of mitochondrial diseases associated with
mtDNA mutations/deletions, ClpP is not induced and is even repressed
in two conditions of mtDNA deletion when compared with their respec-
tive controls (Cortopassi et al., 2006). Yet, among shared overexpressed
genes between the different models of mitochondrial dysfunction, these
authors highlighted ISR targets such as CHOP-10, ATF4, ATF3 and Trib3.
Four, in addition to organelle dysfunction associated with altered
mtDNA expression, mitochondrial proteotoxic stress in mice knock out
for the mitochondrial intermembrane space protease HtrA2 also points
CHOP-10, ATF3 and HERP as overexpressed in brain cells, whereas
ClpP andHSPD1 expression stays unchanged (Moisoi et al., 2009). Finally,
a transcriptomic analysis following the selective inhibition of heat shock
protein-90 (Hsp90) inmitochondria by GamitrinibTPP (GAmitochondrial
matrix inhibitor G-TPP) revealed increased mRNA abundance of
CHOP-10, Trib3, ATF3 and HERP together with phosphorylation of
eIF2α (Siegelin et al., 2011). Altogether these results strongly suggest
that ISR might be a general response to mitochondrial dysfunction
while mtUPR would be restricted to more specific conditions affecting
mitochondrial function.
Coordination between nuclear andmitochondrial genomes is neces-
sary to ensure proper organelle function and cell integrity. The central
ISR event eIF2α phosphorylation might be crucial for such coordination
in response to mitochondrial dysfunction (Fig. 7). Interestingly,
in C. elegans the GCN2-eIF2α axis acts in parallel with mtUPR to keep
mitochondrial proteostasis and function. Indeed, GCN2 silencing in-
creases mitochondrial stress and transcriptional activity of the HSP60-
GFP reporter plasmid (Baker et al., 2012). Global attenuation of protein
synthesis might also prevent excessive importation and accumulation
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whelming of resident chaperones and proteases.
This scenario is already well described for the endoplasmic reticu-
lum. Indeed, it has been shown that eIF2α phosphorylation and protein
synthesis shutdown reduce ER-stress, promoting cell survival (Han
et al., 2013; Harding et al., 2000). Likewise, reduced protein translation
in mouse β-cells is required to keep organelle in shape as cells lacking
eIF2α have swollen mitochondria with disrupted cristae (Back et al.,
2009). Reduced cytosolic protein synthesis also prevents mitochondrial
degeneration in a yeast model of aging-related degenerative disease
(Wang et al., 2008). PINK1 is a serine/threonine kinase involved in the
mitochondrial quality control mitophagy. In a Drosophila melanogaster
model of familial, early onset of Parkinson's disease, reduction of protein
translation suppresses PINK1 mutant phenotype whereas increased
translation through S6K activation worsen it (Liu and Lu, 2010). Finally,
phosphorylation of eIF2α also protects from oxidative stress triggered
by the mitochondrial complex I inhibitor paraquat, both in C. elegans
and mammalian cells (Rainbolt et al., 2013).
The phosphorylation of eIF2α and global attenuation of protein syn-
thesis represent thus an interesting mechanism to prevent/attenuate
mitochondrial damage and dysfunction. Knowing that impaired mito-
chondrial translation is increasingly associated with mitochondrial dis-
eases such as Leigh syndrome and Perrault syndrome (Boczonadi and
Horvath, 2014; Pearce et al., 2013), further investigation of the function-
al impact of the GCN2/P-eIF2α/ATF4 axis is now necessary to better
understand the biological processes controlled by this cell signaling path-
way associated with mitochondria dysfunction and related pathologies.
Acknowledgments
S. Michel is recipient of a doctoral fellowship from the Fonds pour la
Recherche dans l'Industrie et l'Agriculture (FRIA, Belgium). This work
was supported by the Belgian Association for Muscular Diseases
(ABMM, Belgium, grant 2013-08). The authors especially thank Prof.
Wiesner for the gift of the mtDNA-depleted HeLa rho0 cells.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.mito.2015.01.005.
References
Acharya, P., Engel, J.C., Correia,M.A., 2009. Hepatic CYP3A suppression by high concentrations
of proteasomal inhibitors: a consequence of endoplasmic reticulum (ER) stress induc-
tion, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation
factor 2alpha (eIF2alpha)-kinase (PERK) and general control nonderepressible-2
eIF2alpha kinase (GCN2), and global translational shutoff. Mol. Pharmacol. 76, 503–515.
Aldridge, J.E., Horibe, T., Hoogenraad, N.J., 2007. Discovery of genes activated by the
mitochondrial unfolded protein response (mtUPR) and cognate promoter elements.
PLoS One 2, e874.
Alemi, M., Prigione, A., Wong, A., Schoenfeld, R., DiMauro, S., Hirano, M., et al., 2007. Mi-
tochondrial DNA deletions inhibit proteasomal activity and stimulate an autophagic
transcript. Free Radic. Biol. Med. 42, 32–43.
Arnould, T., Vankoningsloo, S., Renard, P., Houbion, A., Ninane, N., Demazy, C., et al., 2002.
CREB activation induced by mitochondrial dysfunction is a new signaling pathway
that impairs cell proliferation. EMBO J. 21, 53–63.
Averous, J., Bruhat, A., Jousse, C., Carraro, V., Thiel, G., Fafournoux, P., 2004. Induction of
CHOP expression by amino acid limitation requires both ATF4 expression and ATF2
phosphorylation. J. Biol. Chem. 279, 5288–5297.
Back, S.H., Scheuner, D., Han, J., Song, B., Ribick, M.,Wang, J., et al., 2009. Translation atten-
uation through eIF2alpha phosphorylation prevents oxidative stress and maintains
the differentiated state in beta cells. Cell Metab. 10, 13–26.
Baker, B.M., Nargund, A.M., Sun, T., Haynes, C.M., 2012. Protective coupling of mitochon-
drial function and protein synthesis via the eIF2alpha kinase GCN-2. PLoS Genet. 8,
e1002760.
Balbi, H.J., 2004. Chloramphenicol: a review. Pediatr. Rev. 25, 284–288.
Biswas, G., Adebanjo, O.A., Freedman, B.D., Anandatheerthavarada, H.K., Vijayasarathy, C.,
Zaidi, M., et al., 1999. Retrograde Ca2+ signaling in C2C12 skeletal myocytes in re-
sponse to mitochondrial genetic and metabolic stress: a novel mode of inter-
organelle crosstalk. EMBO J. 18, 522–533.Biswas, G., Anandatheerthavarada, H.K., Zaidi, M., Avadhani, N.G., 2003. Mitochondria to
nucleus stress signaling: a distinctive mechanism of NFkappaB/Rel activation through
calcineurin-mediated inactivation of IkappaBbeta. J. Cell Biol. 161, 507–519.
Black, M.B., Budinsky, R.A., Dombkowski, A., Cukovic, D., LeCluyse, E.L., Ferguson, S.S., et
al., 2012. Cross-species comparisons of transcriptomic alterations in human and rat
primary hepatocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci.
127, 199–215.
Boczonadi, V., Horvath, R., 2014. Mitochondria: impaired mitochondrial translation in
human disease. Int. J. Biochem. Cell Biol. 48, 77–84.
Bruhat, A., Jousse, C., Wang, X.Z., Ron, D., Ferrara, M., Fafournoux, P., 1997. Amino acid lim-
itation induces expression of CHOP, a CCAAT/enhancer binding protein-related gene,
at both transcriptional and post-transcriptional levels. J. Biol. Chem. 272,
17588–17593.
Bruning, A., Brem, G.J., Vogel, M., Mylonas, I., 2014. Tetracyclines cause cell stress-
dependent ATF4 activation and mTOR inhibition. Exp. Cell Res. 320, 281–289.
Calvo, S.E., Mootha, V.K., 2010. The mitochondrial proteome and human disease. Annu.
Rev. Genomics Hum. Genet. 11, 25–44.
Castilho, B.A., Shanmugam, R., Silva, R.C., Ramesh, R., Himme, B.M., Sattlegger, E., 2014.
Keeping the eIF2 alpha kinase Gcn2 in check. Biochim. Biophys. Acta 1843,
1948–1968.
Chandel, N.S., Schumacker, P.T., 1999. Cells depleted of mitochondrial DNA (rho0) yield
insight into physiological mechanisms. FEBS Lett. 454, 173–176.
Chopra, I., Hawkey, P.M., Hinton, M., 1992. Tetracyclines, molecular and clinical aspects.
J. Antimicrob. Chemother. 29, 245–277.
Cortopassi, G., Danielson, S., Alemi, M., Zhan, S.S., Tong, W., Carelli, V., et al., 2006. Mito-
chondrial disease activates transcripts of the unfolded protein response and cell
cycle and inhibits vesicular secretion and oligodendrocyte-specific transcripts. Mito-
chondrion 6, 161–175.
Dogan, S.A., Pujol, C., Maiti, P., Kukat, A., Wang, S., Hermans, S., et al., 2014. Tissue-specific
loss of DARS2 activates stress responses independently of respiratory chain deficien-
cy in the heart. Cell Metab. 19, 458–469.
Donnelly, N., Gorman, A.M., Gupta, S., Samali, A., 2013. The eIF2alpha kinases: their struc-
tures and functions. Cell. Mol. Life Sci. 70, 3493–3511.
Fujihara, M., Bartels, E., Nielsen, L.B., Handa, J.T., 2009. A human apoB100 transgenic
mouse expresses human apoB100 in the RPE and develops features of early AMD.
Exp. Eye Res. 88, 1115–1123.
Fujita, Y., Ito, M., Nozawa, Y., Yoneda, M., Oshida, Y., Tanaka, M., 2007. CHOP (C/EBP ho-
mologous protein) and ASNS (asparagine synthetase) induction in cybrid cells har-
boring MELAS and NARP mitochondrial DNA mutations. Mitochondrion 7, 80–88.
Goto, Y., Nonaka, I., Horai, S., 1990. A mutation in the tRNA(Leu)(UUR) gene associated
with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348,
651–653.
Guyton, K.Z., Xu, Q., Holbrook, N.J., 1996. Induction of the mammalian stress response
gene GADD153 by oxidative stress: role of AP-1 element. Biochem. J. 314 (Pt 2),
547–554.
Han, J., Back, S.H., Hur, J., Lin, Y.H., Gildersleeve, R., Shan, J., et al., 2013. ER-stress-induced
transcriptional regulation increases protein synthesis leading to cell death. Nat. Cell
Biol. 15, 481–490.
Harding, H.P., Zhang, Y., Bertolotti, A., Zeng, H., Ron, D., 2000. Perk is essential for transla-
tional regulation and cell survival during the unfolded protein response. Mol. Cell 5,
897–904.
Harding, H.P., Zhang, Y., Zeng, H., Novoa, I., Lu, P.D., Calfon, M., et al., 2003. An integrated
stress response regulates amino acid metabolism and resistance to oxidative stress.
Mol. Cell 11, 619–633.
Horibe, T., Hoogenraad, N.J., 2007. The chop gene contains an element for the positive
regulation of the mitochondrial unfolded protein response. PLoS One 2, e835.
Houtkooper, R.H., Mouchiroud, L., Ryu, D., Moullan, N., Katsyuba, E., Knott, G., et al., 2013.
Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 497,
451–457.
Ishikawa, F., Akimoto, T., Yamamoto, H., Araki, Y., Yoshie, T., Mori, K., et al., 2009. Gene ex-
pression profiling identifies a role for CHOP during inhibition of themitochondrial re-
spiratory chain. J. Biochem. 146, 123–132.
James, A.M., Wei, Y.H., Pang, C.Y., Murphy, M.P., 1996. Altered mitochondrial function in
fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. Biochem. J.
318 (Pt 2), 401–407.
Jiang, H.Y., Wek, R.C., 2005. Phosphorylation of the alpha-subunit of the eukaryotic
initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in
response to proteasome inhibition. J. Biol. Chem. 280, 14189–14202.
Kilberg, M.S., Shan, J., Su, N., 2009. ATF4-dependent transcription mediates signaling of
amino acid limitation. Trends Endocrinol. Metab. 20, 436–443.
Kotokorpi, P., Ellis, E., Parini, P., Nilsson, L.M., Strom, S., Steffensen, K.R., et al., 2007. Phys-
iological differences between human and rat primary hepatocytes in response to liver
X receptor activation by 3-[3-[N-(2-chloro-3-trifluoromethylbenzyl)-(2,2-
diphenylethyl)amino]propyloxy]phe nylacetic acid hydrochloride (GW3965). Mol.
Pharmacol. 72, 947–955.
Lenaz, G., Baracca, A., Carelli, V., D'Aurelio, M., Sgarbi, G., Solaini, G., 2004. Bioenergetics of
mitochondrial diseases associated with mtDNA mutations. Biochim. Biophys. Acta
1658, 89–94.
Liu, S., Lu, B., 2010. Reduction of protein translation and activation of autophagy protect
against PINK1 pathogenesis in Drosophila melanogaster. PLoS Genet. 6, e1001237.
Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25,
402–408.
Maceluch, J.A., Niedziela, M., 2006. The clinical diagnosis and molecular genetics of
Kearns–Sayre syndrome: a complex mitochondrial encephalomyopathy. Pediatr.
Endocrinol. Rev. 4, 117–137.
68 S. Michel et al. / Mitochondrion 21 (2015) 58–68Martinus, R.D., Garth, G.P., Webster, T.L., Cartwright, P., Naylor, D.J., Hoj, P.B., et al., 1996.
Selective induction of mitochondrial chaperones in response to loss of the mitochon-
drial genome. Eur. J. Biochem. 240, 98–103.
Mascarenhas, C., Edwards-Ingram, L.C., Zeef, L., Shenton, D., Ashe, M.P., Grant, C.M., et al.,
2008. Gcn4 is required for the response to peroxide stress in the yeast Saccharomyces
cerevisiae. Mol. Biol. Cell 19, 2995–3007.
Mercy, L., Pauw, A., Payen, L., Tejerina, S., Houbion, A., Demazy, C., et al., 2005. Mitochon-
drial biogenesis in mtDNA-depleted cells involves a Ca2 + -dependent pathway and
a reduced mitochondrial protein import. FEBS J. 272, 5031–5055.
Mineri, R., Pavelka, N., Fernandez-Vizarra, E., Ricciardi-Castagnoli, P., Zeviani, M., Tiranti,
V., 2009. How do human cells react to the absence of mitochondrial DNA? PLoS
One 4, e5713.
Miranda, S., Foncea, R., Guerrero, J., Leighton, F., 1999. Oxidative stress and upregulation
of mitochondrial biogenesis genes in mitochondrial DNA-depleted HeLa cells.
Biochem. Biophys. Res. Commun. 258, 44–49.
Moisoi, N., Klupsch, K., Fedele, V., East, P., Sharma, S., Renton, A., et al., 2009.Mitochondrial
dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific
transcriptional stress response. Cell Death Differ. 16, 449–464.
Mouchiroud, L., Houtkooper, R.H., Moullan, N., Katsyuba, E., Ryu, D., Canto, C., et al., 2013.
The NAD(+)/sirtuin pathway modulates longevity through activation of mitochon-
drial UPR and FOXO signaling. Cell 154, 430–441.
Moudy, A.M., Handran, S.D., Goldberg, M.P., Ruffin, N., Karl, I., Kranz-Eble, P., et al., 1995.
Abnormal calcium homeostasis and mitochondrial polarization in a human encepha-
lomyopathy. Proc. Natl. Acad. Sci. U. S. A. 92, 729–733.
Neznanov, N., Dragunsky, E.M., Chumakov, K.M., Neznanova, L., Wek, R.C., Gudkov, A.V., et
al., 2008. Different effect of proteasome inhibition on vesicular stomatitis virus and
poliovirus replication. PLoS One 3, e1887.
Pearce, S., Nezich, C.L., Spinazzola, A., 2013. Mitochondrial diseases: translation matters.
Mol. Cell. Neurosci. 55, 1–12.
Pellegrino,M.W., Nargund, A.M., Haynes, C.M., 2013. Signaling themitochondrial unfolded
protein response. Biochim. Biophys. Acta 1833, 410–416.
Piechota, J., Szczesny, R., Wolanin, K., Chlebowski, A., Bartnik, E., 2006. Nuclear and mito-
chondrial genome responses in HeLa cells treated with inhibitors of mitochondrial
DNA expression. Acta Biochim. Pol. 53, 485–495.
Rainbolt, T.K., Atanassova, N., Genereux, J.C., Wiseman, R.L., 2013. Stress-regulated trans-
lational attenuation adapts mitochondrial protein import through Tim17A degrada-
tion. Cell Metab. 18, 908–919.
Rath, E., Berger, E., Messlik, A., Nunes, T., Liu, B., Kim, S.C., et al., 2012. Induction of dsRNA-
activated protein kinase links mitochondrial unfolded protein response to the patho-
genesis of intestinal inflammation. Gut 61, 1269–1278.
Richter, U., Lahtinen, T., Marttinen, P., Myohanen, M., Greco, D., Cannino, G., et al., 2013. A
mitochondrial ribosomal and RNA decay pathway blocks cell proliferation. Curr. Biol.
23, 535–541.
Ryan, M.T., Hoogenraad, N.J., 2007. Mitochondrial-nuclear communications. Annu. Rev.
Biochem. 76, 701–722.
Schroder, M., Kaufman, R.J., 2005. The mammalian unfolded protein response. Annu. Rev.
Biochem. 74, 739–789.
Seidel-Rogol, B.L., Shadel, G.S., 2002. Modulation of mitochondrial transcription in re-
sponse to mtDNA depletion and repletion in HeLa cells. Nucleic Acids Res. 30,
1929–1934.Seok, J., Warren, H.S., Cuenca, A.G., Mindrinos, M.N., Baker, H.V., Xu, W., et al., 2013. Geno-
mic responses in mouse models poorly mimic human inflammatory diseases. Proc.
Natl. Acad. Sci. U. S. A. 110, 3507–3512.
Shoffner, J.M., Lott, M.T., Lezza, A.M., Seibel, P., Ballinger, S.W., Wallace, D.C., et al., 1990.
Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mito-
chondrial DNA tRNA(Lys) mutation. Cell 61, 931–937.
Siegelin, M.D., Dohi, T., Raskett, C.M., Orlowski, G.M., Powers, C.M., Gilbert, C.A., et al.,
2011. Exploiting the mitochondrial unfolded protein response for cancer therapy in
mice and human cells. J. Clin. Invest. 121, 1349–1360.
Silva, J.M., Wong, A., Carelli, V., Cortopassi, G.A., 2009. Inhibition of mitochondrial function
induces an integrated stress response in oligodendroglia. Neurobiol. Dis. 34, 357–365.
Ubeda, M., Habener, J.F., 2000. CHOP gene expression in response to endoplasmic-
reticular stress requires NFY interaction with different domains of a conserved
DNA-binding element. Nucleic Acids Res. 28, 4987–4997.
Ubeda, M., Habener, J.F., 2003. CHOP transcription factor phosphorylation by casein
kinase 2 inhibits transcriptional activation. J. Biol. Chem. 278, 40514–40520.
Vafai, S.B., Mootha, V.K., 2012. Mitochondrial disorders as windows into an ancient organ-
elle. Nature 491, 374–383.
van den Bogert, C., van Kernebeek, G., de Leij, L., Kroon, A.M., 1986. Inhibition of mito-
chondrial protein synthesis leads to proliferation arrest in the G1-phase of the cell
cycle. Cancer Lett. 32, 41–51.
van der Sanden, M.H., Meems, H., Houweling, M., Helms, J.B., Vaandrager, A.B., 2004. In-
duction of CCAAT/enhancer-binding protein (C/EBP)-homologous protein/growth ar-
rest and DNA damage-inducible protein 153 expression during inhibition of
phosphatidylcholine synthesis is mediated via activation of a C/EBP-activating tran-
scription factor-responsive element. J. Biol. Chem. 279, 52007–52015.
Vankoningsloo, S., De Pauw, A., Houbion, A., Tejerina, S., Demazy, C., de Longueville, F., et
al., 2006. CREB activation induced by mitochondrial dysfunction triggers triglyceride
accumulation in 3T3-L1 preadipocytes. J. Cell Sci. 119, 1266–1282.
Vattem, K.M.,Wek, R.C., 2004. Reinitiation involving upstreamORFs regulates ATF4mRNA
translation in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 101, 11269–11274.
Vives-Bauza, C., Gonzalo, R., Manfredi, G., Garcia-Arumi, E., Andreu, A.L., 2006. Enhanced
ROS production and antioxidant defenses in cybrids harbouring mutations in
mtDNA. Neurosci. Lett. 391, 136–141.
Wang, X.Z., Ron, D., 1996. Stress-induced phosphorylation and activation of the transcrip-
tion factor CHOP (GADD153) by p38 MAP kinase. Science 272, 1347–1349.
Wang, X., Zuo, X., Kucejova, B., Chen, X.J., 2008. Reduced cytosolic protein synthesis sup-
presses mitochondrial degeneration. Nat. Cell Biol. 10, 1090–1097.
Wek, R.C., Jiang, H.Y., Anthony, T.G., 2006. Coping with stress: eIF2 kinases and transla-
tional control. Biochem. Soc. Trans. 34, 7–11.
Zhao, Q., Wang, J., Levichkin, I.V., Stasinopoulos, S., Ryan, M.T., Hoogenraad, N.J., 2002. A
mitochondrial specific stress response in mammalian cells. EMBO J. 21, 4411–4419.
Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Lightfoot, R.T., Remotti, H., et al., 1998.
CHOP is implicated in programmed cell death in response to impaired function of the
endoplasmic reticulum. Genes Dev. 12, 982–995.
